Patients with MEN 2 syndrome warrant particular attention, as this hereditary condition predisposes to MTC, pheochromocytoma, and parathyroid adenomas
Semaglutide is FDA-approved and available now
Tirzepatide reconstitution follows similar principles to semaglutide, and our tirzepatide reconstitution guide and tirzepatide dosing guide provide formulation-specific details
In hemodialysis patients with carnitine deficiency, intravenous L-Carnitine (1040 mg/kg after dialysis sessions) significantly increased plasma carnitine levels, reduced fatigue, and preserved exercise capacity over 24 weeks with excellent tolerability [5]
Notably, after a 4-week washout period these beneficial effects diminished, with the exception of clinical severity scores